Pub. Date : 2010 Jan 14
PMID : 20074357
10 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
1 | Differential requirement of the epidermal growth factor receptor for G protein-mediated activation of transcription factors by lysophosphatidic acid. | lysophosphatidic acid | epidermal growth factor receptor | Homo sapiens |
2 | The purpose of the current study is to identify EGFR-mediated mechanisms involved in activation of G protein cascades and the downstream transcription factors by lysophosphatidic acid (LPA). | lysophosphatidic acid | epidermal growth factor receptor | Homo sapiens |
3 | The purpose of the current study is to identify EGFR-mediated mechanisms involved in activation of G protein cascades and the downstream transcription factors by lysophosphatidic acid (LPA). | lysophosphatidic acid | epidermal growth factor receptor | Homo sapiens |
4 | RESULTS: In ovarian cancer cells highly responsive to LPA, activation of AP-1 by LPA was suppressed by inhibition of EGFR, an effect that could be reversed by co-stimulation of another receptor tyrosine kinase c-Met with hepatocyte growth factor, indicating that LPA-mediated activation of AP-1 requires activity of a RTK, not necessarily EGFR. | lysophosphatidic acid | epidermal growth factor receptor | Homo sapiens |
5 | RESULTS: In ovarian cancer cells highly responsive to LPA, activation of AP-1 by LPA was suppressed by inhibition of EGFR, an effect that could be reversed by co-stimulation of another receptor tyrosine kinase c-Met with hepatocyte growth factor, indicating that LPA-mediated activation of AP-1 requires activity of a RTK, not necessarily EGFR. | lysophosphatidic acid | epidermal growth factor receptor | Homo sapiens |
6 | RESULTS: In ovarian cancer cells highly responsive to LPA, activation of AP-1 by LPA was suppressed by inhibition of EGFR, an effect that could be reversed by co-stimulation of another receptor tyrosine kinase c-Met with hepatocyte growth factor, indicating that LPA-mediated activation of AP-1 requires activity of a RTK, not necessarily EGFR. | lysophosphatidic acid | epidermal growth factor receptor | Homo sapiens |
7 | RESULTS: In ovarian cancer cells highly responsive to LPA, activation of AP-1 by LPA was suppressed by inhibition of EGFR, an effect that could be reversed by co-stimulation of another receptor tyrosine kinase c-Met with hepatocyte growth factor, indicating that LPA-mediated activation of AP-1 requires activity of a RTK, not necessarily EGFR. | lysophosphatidic acid | epidermal growth factor receptor | Homo sapiens |
8 | RESULTS: In ovarian cancer cells highly responsive to LPA, activation of AP-1 by LPA was suppressed by inhibition of EGFR, an effect that could be reversed by co-stimulation of another receptor tyrosine kinase c-Met with hepatocyte growth factor, indicating that LPA-mediated activation of AP-1 requires activity of a RTK, not necessarily EGFR. | lysophosphatidic acid | epidermal growth factor receptor | Homo sapiens |
9 | RESULTS: In ovarian cancer cells highly responsive to LPA, activation of AP-1 by LPA was suppressed by inhibition of EGFR, an effect that could be reversed by co-stimulation of another receptor tyrosine kinase c-Met with hepatocyte growth factor, indicating that LPA-mediated activation of AP-1 requires activity of a RTK, not necessarily EGFR. | lysophosphatidic acid | epidermal growth factor receptor | Homo sapiens |
10 | In contrast, LPA stimulated another prominent transcription factor NF-kappaB via the Gq-PKC pathway in an EGFR-independent manner. | lysophosphatidic acid | epidermal growth factor receptor | Homo sapiens |